The Board of Directors of BioSyent Inc. announced the appointment of Stephen Wilton to the company's Board. Wilton brings to BioSyent over 28 years of experience in the pharmaceutical industry. After working in medical sales and marketing positions at Eli Lilly Canada he joined AstraZeneca Canada where he enjoyed a long and varied career.

After his 17 year career at AstraZeneca, Mr. Wilton worked as Vice President of Pharmacy Affairs for the Canadian Association of Chain Drug Stores representing the interests of owners and pharmacists in the Canadian healthcare system.